Pfizer (PFE) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Pfizer · Cost of Revenue

PFE Cost of Revenue

Latest reported$18.27Bperiod endingJun 28, 2026

PFE Cost of Revenue ($1.42B → $18.27B)

Annual cost of revenue

High-resolution chart · PNG

PFE cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	18,565,000,000
Dec 31, 2024	21,781,000,000
Dec 31, 2023	29,213,000,000
Dec 31, 2022	38,240,000,000
Dec 31, 2021	34,413,000,000
Dec 31, 2020	11,771,000,000
Dec 31, 2019	12,623,000,000
Dec 31, 2018	16,008,000,000
Dec 31, 2017	15,777,000,000
Dec 31, 2016	15,954,000,000
Dec 31, 2015	13,157,000,000
Dec 31, 2014	13,310,000,000
Dec 31, 2013	13,954,000,000
Dec 31, 2012	14,642,000,000
Dec 31, 2011	17,165,000,000
Dec 31, 2010	20,714,000,000
Dec 31, 2009	11,590,000,000
Dec 31, 2008	10,035,000,000
Dec 31, 2007	11,725,000,000
Dec 31, 2006	10,509,000,000
Dec 31, 2005	10,507,000,000
Dec 31, 2004	10,905,000,000
Dec 31, 2003	9,832,000,000
Dec 31, 2002	4,045,000,000
Dec 31, 2001	5,034,000,000
Dec 31, 2000	4,059,000,000
Dec 31, 1999	1,986,000,000
Dec 31, 1998	1,605,000,000
Dec 31, 1997	1,772,000,000
Dec 31, 1996	1,746,000,000
Dec 31, 1995	1,790,100,000
Dec 31, 1994	1,626,600,000
Dec 31, 1993	1,513,800,000
Dec 31, 1992	1,760,400,000
Dec 31, 1991	1,956,500,000
Dec 31, 1990	2,034,600,000
Dec 31, 1989	1,855,200,000
Dec 31, 1988	1,825,600,000
Dec 31, 1987	1,734,900,000
Dec 31, 1986	1,573,300,000
Dec 31, 1985	1,416,200,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.